Friday, October 23, 2020

October 23: 3,874 New COVID 19 Cases in Illinois

Boone County is reporting an increase of 18 COVID-19 cases. The Illinois Department of Public Health (IDPH) today reported 3,874 new confirmed cases of coronavirus disease (COVID-19) in Illinois, including 31 additional deaths.


October 23: Johns Hopkins COVID 19 Report

COVID-19

Updates on the COVID-19 pandemic from the Johns Hopkins Center for Health Security.

Additional resources are available on our website.

Subscribe to our newsletter

The Johns Hopkins Center for Health Security also produces US Travel Industry and Retail Supply Chain Updates that provide a summary of major issues and events impacting the US travel industry and retail supply chain. You can access them here.

SYSTEMIC RACISM & COVID-19 The Johns Hopkins Center for Health Security’s journal, Health Security, issued a call for papers for an upcoming Special Feature on systemic racism in the context of the COVID-19 pandemic (scheduled for May/June 2021). The COVID-19 pandemic’s impacts on health, economies, and social structures have disproportionately impacted racially marginalized populations. Racial and ethnic minority communities are experiencing elevated COVID-19 morbidity and mortality, stemming in part from ineffective response efforts and longstanding barriers to accessing healthcare and public health programs and services. Evidence-based and peer-reviewed research is urgently needed to examine the root causes and impacts of systemic and pervasive racial and ethnic inequities in the context of COVID-19 as well as how systemic racism manifests in the practice of health security, including in preparedness for, response to, and recovery from COVID-19. The journal is actively encouraging submissions from women, underrepresented minority scholars in health security, and scholars with disabilities. Additional information is available here.

EPI UPDATE The WHO COVID-19 Dashboard reports 41.57 million cases and 1.13 million deaths as of 9:30am EDT on October 23.

The US surpassed India in terms of daily incidence, resuming the #1 position globally with approximately 60,000 new cases per day. This means that the US is again increasing its lead over #2 India in terms of cumulative COVID-19 incidence.

The current COVID-19 resurgence in Europe and the US have been well covered globally, as well as India’s epidemic and the high-profile success of countries like New Zealand. Today, we briefly discuss global trends in COVID-19 incidence, with a specific focus on parts of the world that are receiving less attention recently.

Notably, Central and South America, which were major global hotspots several months ago, are largely reporting decreasing COVID-19 incidence, as is the nearby Caribbean region. While there are some exceptions, many countries in Sub-Saharan Africa are reporting decreasing incidence as well. Additionally, daily incidence is decreasing in most of the Eastern Mediterranean region, which includes numerous countries that previously reported among the highest per capita incidence in the world. This trend continues across much of South and Southeast Asia as well, including India, which has reported a decrease of 40% over the past 5 weeks.

These trends can also be observed on a continental level, with incidence decreasing in South America and Asia (driven principally by India), increasing moderately in North America, and increasing more sharply in Europe (nearly doubling over the past 2 weeks). Incidence in Oceania is increasing sharply as well, but Oceania has generally reported very low incidence over the course of the pandemic, so even minor absolute increases result in large relative changes. Similarly, incidence in Africa appears to be increasing at approximately the same rate as North America, but this is a result of a much smaller absolute change due to Africa’s generally low incidence, particularly on a per capita basis.

UNITED STATES

The US CDC reported 8.31 million total cases and 221,438 deaths. The daily COVID-19 incidence continues to increase, now up to 59,699 new cases per day, the highest since August 3. Following the previous peak (66,960 new cases per day on July 24), the US daily incidence fell by 48% to its most recent low (34,371 new cases per day on September 12). Since that time, however, the US has climbed more than 75% of the way back to its highest peak, and still increasing steadily.

The US COVID-19 mortality increased for the third consecutive day, up from approximately 700 deaths per day to 773—a 10% increase and the highest average since September 19. It is still too early to determine if this is the beginning of a longer-term trend.

More than half of all US states have reported more than 100,000 cases, including 10 with more than 200,000 cases:

>800,000: California, Texas

>700,000: Florida

>400,000: New York

>300,000: Georgia, Illinois

>200,000: Arizona, New Jersey, North Carolina, Tennessee

Wisconsin is averaging more than 3,500 new cases per day over the past week, so we expect it to surpass 200,000 cumulative cases in the next several days.

The Johns Hopkins CSSE dashboard reported 8.43 million US cases and 223,289 deaths as of 12:30pm EDT on October 21.

LOMBARDY, ITALY Early in the COVID-19 pandemic, Italy’s Lombardy region was one of the most severely affected parts of the world. According to Italy’s Ministry of Health, the region has reported more than 143,000 total cases, including more than 17,000 deaths. The initial patient surge overwhelmed Lombardy’s health system, and approximately 12,000 healthcare workers were infected. In order to better understand the impacts and drivers of the epidemic, the Regional Council of Lombardy created a “COVID-19 investigative commission.” The commission will “analyse the sequence of events and the specific choices that led to so many infections and deaths” with the aim of learning and sharing lessons and providing “accountability [for] the Italian people.” The commission will assess a variety of data and include input from technical experts in order to characterize the COVID-19 epidemiology, response, and effects on the region. A member of the commission indicated that this effort is the first of its kind in Europe, and possibly globally.

IRELAND Ireland is implementing one of the most restrictive sets of social distancing measures in Europe in response to its “second wave” of COVID-19. This week, Ireland entered Phase 5 “lockdown,” the highest level in Ireland, which includes restrictions on social gatherings (indoors and outdoors), including weddings and funerals; religious services; retail businesses, restaurants, cafes, and pubs; essential services; sporting events and outdoor activities; and travel, hotels, and public transportation. Notably, schools and childcare services will remain open in Phase 5. Households are permitted to form a “support bubble” with one other household, under specific circumstances. The Irish government is also increasing financial assistance for unemployed individuals under Phase 5. The Phase 5 restrictions are currently scheduled to last at least 6 weeks. In early October, when Ireland was at Phase 2, senior medical experts in Ireland reportedly called on the government to move immediately to Phase 5, arguing that this was the only option to contain transmission while keeping schools open; however, Ireland moved one step to Phase 3, which still permitted many aspects of social and economic activity to continue. Ireland has reported nearly 55,000 cases and more than 1,800 deaths, and its daily incidence has increased by a factor of 11 since early September, setting new records there.

KENYA Following efforts by the Kenyan government to ease social and economic restrictions, Kenya is reporting a second surge in COVID-19 incidence. The policy changes included shifting the start of a nationwide curfew to a later hour in order to support bars and restaurants and a partial reopening of public schools. Kenyan President Uhuru Kenyatta announced the changes during a national address in late September, in which he discussed the challenges Kenya endured over the early stage of the pandemic and called for continued vigilance by Kenyans to contain the virus. The restrictions implemented in response to Kenya’s “first wave” of transmission enabled the country to largely bring its epidemic under control; however, Kenya has seen a steady increase in COVID-19 activity since mid-to-late September. Since its low of 118 new cases per day on September 21, Kenya’s daily incidence has increased by a factor of 5. It has nearly returned to the height of its first peak and is still increasing rapidly.

KYRGYZSTAN The government’s response to COVID-19 has added fuel to protests in Kyrgyzstan that started in opposition to disputed results of the country’s parliamentary election. In addition to concerns about the validity of the election results, protestors expressed frustration with the lack of government support during the national “lockdown.” According to a report by Reuters, some protestors indicated that citizens were largely left to “fend for themselves,” which has contributed to growing anger and opposition toward government leadership. Kyrgyzstan relies on external travel with China and Russia to support the national economy, and many have argued that the government did not do enough to support their citizens financially following the border closure and travel restrictions. COVID-19 daily incidence has been increasing in Kyrgyzstan since its low in mid-September, increasing from approximately 57 new cases per day to more than 500 over that time.

WHO REFORM The German government and the EU reportedly drafted a document calling for reforms that aim to increase transparency by the WHO. The WHO has received criticism over the course of the COVID-19 pandemic, including for a perceived shortage of information shared publicly in the pandemic’s early stages. US President Donald Trump has repeatedly cited a lack of transparency, with a particular focus on China, as one of the primary reasons for his decision to withdraw the US from the WHO. According to a report by Reuters, the document is part of an ongoing EU effort to improve WHO’s capabilities. The report also indicates that the EU proposal aims to reduce the impact of “political influence” on WHO activities and reporting as well as increase funding and address the WHO’s lack of legal authority to take and compel action around health issues. The proposal is still in draft form and, to our knowledge, has not yet been published publicly.

GERMANY Following a recent surge to more than 10,000 new cases per day, Germany issued travel warnings for nearby European countries, including popular tourist destinations such as Austria, Italy, and Switzerland. Returning travelers from these countries must self-quarantine for 10 days; however, if the individual tests negative after the fifth day, they can end their quarantine period early. The new travel policies take effect on October 24, and they are an expansion of previously issued warnings corresponding for more than 10 European countries, based on the Robert Koch Institute's list of high-risk areas. Countries across Europe are facing a severe resurgence of COVID-19, worse than the “first wave” in many countries. While the new measures may impact tourism to affected regions or countries, other tourist regions such as Spain’s Canary Islands have recently been removed from the Robert Koch Institute’s list of high-risk areas.

Additionally, German Health Minister Jens Spahn recently tested positive for SARS-CoV-2. While Minister Spahn is in isolation and reportedly exhibiting “cold-like symptoms,” no other members of Chancellor Angela Merkel’s cabinet will be subjected to quarantine, despite having contact with Minister Spahn earlier in the week. The extent of the contact between Minister Spahn and other cabinet members is unclear; however, government officials indicated that quarantine is not warranted, based on Germany’s public health guidelines.

US CDC UPDATES “CLOSE CONTACT” DEFINITION The US CDC published updated guidance regarding the definition of “close contact” for COVID-19. The new iteration of the guidance indicates that even brief contact with infectious individuals could result in transmission. Both the previous version and the newest iteration define close contact as being within 6 feet of an infectious individual for 15 minutes, but the new version notes that the time is cumulative over a 24-hour period. This could include being within 6 feet of an infectious individual for 3 separate periods of 5 minutes each, whereas the previous version was generally understood as referring to a single, prolonged exposure period. The CDC guidance continues to emphasize that it is difficult to concretely define what qualifies as close contact and that the guidance is an “operational definition for contact investigation.”

The change was reported motivated by a case study recently published in the US CDC’s MMWR. The study documents suspected SARS-CoV-2 transmission over the course of multiple short exposure periods. The event occurred at a correctional facility in Vermont (US), and a correctional officer was infected after “multiple brief encounters with six incarcerated...persons” who were awaiting the results of SARS-CoV-2 tests after their arrival at the facility. All 6 individuals ultimately received positive test results. Review of video surveillance showed that the correctional officer was not within 6 feet of any of the individuals for a 15-minute period, and therefore, he was not identified as a close contact. The officer was not included in contact tracing efforts, and he was permitted to continue working. He later developed COVID-19 symptoms and tested positive for SARS-CoV-2. Further evaluation of the surveillance video found that the correctional officer was within 6 feet of the infected incarcerated individuals at least 22 times, totaling approximately 17 minutes over the course of an 8-hour shift. This example illustrates that SARS-CoV-2 transmission can occur over much shorter periods of contact than suggested by previous CDC guidance.

REMDESIVIR APPROVED The US FDA announced that it approved remdesivir as treatment for COVID-19, the first drug to obtain full regulatory approval (as opposed to an Emergency Use Authorization [EUA]). According to the official announcement, the approval applies to hospitalized COVID-19 patients aged 12 or older and weighing at least 88 pounds (40 kg). Remdesivir’s EUA remains in effect for hospitalized pediatric patients under the age of 12 and weighing at least 7.7 pounds (3.5 kg) and for hospitalized patients aged 12 and older and weighing 7.7-88 pounds (3.5-40kg). The FDA’s decision was based on the findings from 3 randomized controlled trials that demonstrated a statistically significant effect in terms of speeding recovery among hospitalized COVID-19 patients. However, the trials did not identify an improvement in the odds of recovery/reduction in mortality.

VACCINE CLINICAL TRIALS Moderna Therapeutics completed enrollment of the Phase 3 clinical trial for its candidate SARS-CoV-2 vaccine. The trial enrolled 30,000 participants, including more than 12,000 Americans who are over the age of 65 or have high-risk health conditions. Approximately 42% of the total trial population is at elevated risk for severe COVID-19 disease and death, including those with a myriad of underlying health conditions: diabetes (36%), severe obesity (25%), severe cardiac disease (19%), and chronic lung disease (18%). Additionally, 37% of enrollees are racial or ethnic minorities. Notably, 10% of all enrollees are Black, 20% are Hispanic or Latinx, and 4% are Asian. Black enrollment in the study is slightly lower than the proportion of Black individuals in the overall US population, but the diversity of the participants has been viewed positively, particularly considering that Moderna faced challenges enrolling participants from certain racial and ethnic minority groups.

It was widely reported this week that a participant enrolled in the Phase 3 clinical trial for the AstraZeneca/Oxford candidate vaccine trial died, raising concerns about the safety of the vaccine and the clinical trial timeline. The participant was a 28-year-old physician in Brazil who treated COVID-19 patients. However, according to multiple reports, the patient was a member of the control group, and did not receive the candidate SARS-CoV-2 vaccine. Rather, the participant received an approved meningitis vaccine. Because the death was not attributable to an adverse event associated with the candidate vaccine, the trial can continue. Focus has remained centered on developments in the AstraZeneca clinical trials around the world, particularly after the trials in the UK and other countries were paused after a participant was diagnosed with transverse myelitis. The trial has since resumed in the UK and other countries, but not in the US.

October 22: University of Washington COVID-19 Projections

This is a work in progress

October 15: University of Washington COVID-19 Projections
Home

Projections for February 1, 2021  The projections are from:  https://covid19.healthdata.org/united-states-of-america?view=total-deaths&tab=trend

United States   389,087, NOW 385,611 deaths Population 331.00 million 1175.49 per million


Georgia   12,541 NOW 13,456 deaths; Population 3.99 million  3143.11 per million

New York 41,989 NOW 38,5961 deaths; Population 18.8 million  2266.46 per million

Massachusetts  13,761 NOW 13,396 deaths; Population 6.7 million 2043.88 per million

Louisiana   8543 NOW 8572 deaths  Population 4.6 million  1857.17 per million

North Dakota 1147 deaths; Population .762 million  1505.25 per million

Connecticut  5552  deaths; Population  3.7 million  1500.54 per million

District of Columbia 1021  NOW 957 deaths Population .684 million;   1492.69 per million

Illinois 18,305 NOW 18,294 deaths Population 12.63 million  1449..33 per million

Florida   28,656 deaths Population 21.47 million  1334.70 per million

South Carolina 6409 deaths; Population 5.0 million  48.4 per million; 1281.8 per million;

Pennsylvania  16,258 deaths; Population 12.7 million  1280.16 per million;

Arkansas 3860 deaths; Population 3.018 million  1278.99 per million

Iowa  3933 deaths;Population 3.17 million  1240.39 per million

California 36,071 deaths;   Population 39.78 million 1206.39  per million;

Arizona  8,678 deaths;Population 7.29 million  1190.40 per million

Kansas 3237 deaths ;Population  2.77 million 1168.59 per million

Wisconsin  6439 deaths;  Population 5.82 million  1106.36 per million

Colorado  6405 deaths Population 5.8 million  1104.31 per million

South Dakota 950 deaths; Population .885 million 1073.45 per million

Texas    31,301 deaths;   Population 29.90 million 1046.86  per million

Idaho  1711 deaths; Population 1.787 million  957.17 per million

Missouri  5677 deaths; Population 6.137 million; 925.04 per million

Ohio  10,671  deaths Population 11.73 million  909.72 per million;

Virginia 7819 deaths  Population 8.63 million  906.03 per million

Maryland  5203 deaths ; Population 6.0 million  867.17 per million

Oklahoma  2820  deaths;Population 4.0 million  705.0 per million

Washington  4340 deaths; Population 7.17 million  605.30 per million

Oregon  1911 deaths; Population 4.3 million  444.42 per million

Thursday, October 22, 2020

October 22: 4942 New COVID-19 Cases in Illinois

Boone County is reporting 19 new cases of COVID-19. The Illinois Department of Public Health (IDPH) today reported 4,942 new confirmed cases of coronavirus disease (COVID-19) in Illinois, including 44 additional deaths.


No photo description available.

Boone County answers additional questions regarding Maple Crest Nursing Centre

These are the answers which Boone County administration provided to my questions after posting FAQ from the county website: 

1. Currently, are the taxpayers paying any type of property taxes for the operation of Maple Crest Care Centre?

Currently, no property tax revenues are being utilized for the operation of Maple Crest.

2. What are the general terms under the current lease as far as annual rent and maintenance costs? What is the current net loss or gain to the County budget?

The Original Lease Term was for five (5) years, beginning in 1999 and ending in 2003. The First Renewal Term of fifteen (15) years began in 2004 and ended in 2018. Currently, the County and Operator are in the Second Renewal Term of ten (10) years, which began in 2019 and will end in 2028. A Third Renewal Term option was added to the Lease in 2011 for another fifteen (15) years, extending until 2043. The current monthly rent is $12,174. That revenue is deposited into the County’s General Fund (Account No. 360.040 Rent Maple Crest). The operator is responsible for maintenance/repairs.

3. The facility is being operated by a for profit corporation. Are property taxes being paid on the property?  If so what is the amount? What is the assessed valuation of the property both for tax purposes and insurance coverage?  If there is a recent market appraisal, what is that value?

Maple Crest is located on a large parcel that includes a portion of the Belvidere-Boone County Landfill and the Highway Department facility (PIN 05-14-100-015). For that particular PIN, property taxes have been paid in the amount of $52,572 in 2020. According to public information available on the Boone County Property Tax Inquiry webpage, the mailing address for tax purposes is Formation Capital Asset Management (Formation being one of the entities involved in the Maple Crest Lease). The Assessed Value is $573,333. The Sound Insurable Value is $4,603,154 according to the County’s annual revaluation report that was completed in March 2020. County Administration is unaware of any recent market appraisals for Maple Crest.

4. Does the County currently have any say in the patient rates or the number of public aid patients?

These issues are addressed in Section 7.1 of the Lease, which is attached as a PDF.

Dan Streed, Deputy County Administrator


************************************************************************************************

Below is the original posting from 10-17-2020 on Boone County Watchdog


Saturday, October 17, 2020

Boone County finally informs voters a little about the nursing home referendum

On October 16 this short statement of questions and answers appeared on the county’s website:  https://www.boonecountyil.org/sites/default/files/images/Maple%20Crest%20Care%20Centre%20Referendum%20Question%20FAQs.pdf

On September 24 early voting began.

10/16/2020

Maple Crest Care Centre Referendum Question  Frequently Asked Questions

This November, Boone County residents will be asked to vote on whether or not the County Board can  pursue selling Maple Crest Care Centre (Maple Crest). To address common questions related to the  question, we've compiled a list of FAQ’s.

What is Maple Crest Care Centre?  Maple Crest is an 86 bed nursing home facility located at 4452 Squaw Prairie Rd in Belvidere, Illinois. The  existing facility was constructed after a Countywide referendum held on January 7, 1969. The  referendum allowed the County to issue nearly $1M of construction bonds and levy a tax for future debt  service payments. The new facility opened in February 1971.

Does Boone County own and operate Maple Crest Care Centre?  Yes and no. In 1999, due to ever‐increasing financial and operational difficulties associated with  operating a nursing home facility, the Boone County Board voted to outsource the operations of Maple  Crest by leasing the facility to a private organization. Currently, Maple Crest is operated by Symphony  Care Network, a post‐acute care provider with 29 locations throughout the Midwest. Although the  operation of Maple Crest is outsourced, the County retains ownership of the facility and grounds.

What level of care does Maple Crest Care Centre provide to its residents?  Maple Crest is rated as a five‐star facility (the highest rating) by the U.S. Centers for Medicare and  Medicaid Services. The star rating system gives each facility a rating between 1 and 5 stars and includes  an analysis of health inspections, staffing, and quality of resident care measures

What would approval of the referendum mean for the future of Maple Crest Care Centre?  Passage of the ballot question would provide the County Board with the option to pursue selling Maple  Crest in such a manner and upon such terms as it deems best for the interest of the County. The process  for selling/disposing of a County Home is set‐out in the Illinois Counties Code (55 ILCS 5/5‐21001). If the  home was erected after referendum approval, like Maple Crest was, a referendum is required to sell it.

  Without approval of the ballot question, the County Board does not have the option to explore selling  Maple Crest to a private operator. If, after the passage of the ballot question, the County Board did  decide to move forward with selling Maple Crest, the sale would go through the normal public County  Board approval process.

  What are other Illinois counties doing with their County‐owned nursing home facilities?  County‐owned nursing home facilities are becoming increasingly rare in Illinois. Some, such as  Winnebago County, continue to own and operate a nursing home facility. Others, such as Rock Island  County and Champaign County, most recently, have sold their nursing home facilities to private  operators.

Additional Questions?

Boone County Administration Office

1212 Logan Ave, Suite 102

Belvidere, IL 61008

815‐547‐4770

****************************************************************************************************************************************************

Illinois Statute referenced above:

(55 ILCS 5/5-21001) (from Ch. 34, par. 5-21001)
Sec. 5-21001. Establishment and maintenance of county home. In any county which establishes and maintains a county sheltered care home or a county nursing home for the care of infirm or chronically ill persons, as provided in Section 5-1005, the County Board shall have power:
1. To acquire in the name of the county by purchase, grant, gift, or legacy, a suitable tract or tracts of land upon which to erect and maintain the home, and in connection therewith a farm or acreage for the purpose of providing supplies for the home and employment for such patients as are able to work and benefit thereby.
The board shall expend not more than $20,000 for the purchase of any such land or the erection of buildings without a 2/3 vote of all its members in counties of 300,000 or more population, or a favorable vote of at least a majority of all its members in counties under 300,000 population.
2. To receive in the name of the county, gifts and legacies to aid in the erection or maintenance of the home.
3. To appoint a superintendent and all necessary employees for the management and control of the home and to prescribe their compensation and duties.
4. To arrange for physicians' or other health care professionals' services and other medical care for the patients in the home and prescribe the compensation and duties of physicians so designated.
5. To control the admission and discharge of patients in the home.
6. To fix the rate per day, week, or month which it will charge for care and maintenance of the patients. Rates so established may vary according to the amount of care required, but the rates shall be uniform for all persons or agencies purchasing care in the home except rates for persons who are able to purchase their own care may approximate actual cost.
7. To make all rules and regulations for the management of the home and of the patients therein.
8. To make appropriations from the county treasury for the purchase of land and the erection of buildings for the home, and to defray the expenses necessary for the care and maintenance of the home and for providing maintenance, personal care and nursing services to the patients therein, and to cause an amount sufficient for those purposes to be levied upon the taxable property of the counties and collected as other taxes and further providing that in counties with a population of not more than 1,000,000 to levy and collect annually a tax of not to exceed .1% of the value, as equalized or assessed by the Department of Revenue, of all the taxable property in the county for these purposes. The tax shall be in addition to all other taxes which the county is authorized to levy on the aggregate valuation of the property within the county and shall not be included in any limitation of the tax rate upon which taxes are required to be extended, but shall be excluded therefrom and in addition thereto. The tax shall be levied and collected in like manner as the general taxes of the county, and when collected, shall be paid into a special fund in the county treasury and used only as herein authorized. No such tax shall be levied or increased from a rate lower than the maximum rate in any such county until the question of levying such tax has first been submitted to the voters of such county at an election held in such county, and has been approved by a majority of such voters voting thereon. The corporate authorities shall certify the question of levying such tax to the proper election officials, who shall submit the question to the voters at an election held in accordance with the general election law.
The proposition shall be in substantially the following form:
--------------------------------------------------------------
Shall ........ County be authorized
to levy and collect a tax at a rate not            YES
to exceed .1% for the purpose of          --------------------
   ........ (purchasing, maintaining) a            NO
county nursing home?
--------------------------------------------------------------
If a majority of votes cast on the question are in favor, the county shall be authorized to levy the tax.
If the county has levied such tax at a rate lower than the maximum rate set forth in this Section, the county board may increase the rate of the tax, but not to exceed such maximum rate, by certifying the proposition of such increase to the proper election officials for submission to the voters of the county at a regular election in accordance with the general election law. The proposition shall be in substantially the following form:
--------------------------------------------------------------
Shall the maximum rate
of the tax levied by........            YES
County for the purpose of.......
(purchasing, maintaining) a      -----------------------------
county nursing home be
increased from........ to               NO
........ (not to exceed .1%)
--------------------------------------------------------------
If a majority of all the votes cast upon the proposition are in favor thereof, the county board may levy the tax at a rate not to exceed the rate set forth in this Section.
9. Upon the vote of a 2/3 majority of all the members of the board, to sell, dispose of or lease for any term, any part of the home properties in such manner and upon such terms as it deems best for the interest of the county, and to make and execute all necessary conveyances thereof in the same manner as other conveyances of real estate may be made by a county. However, if the home was erected after referendum approval by the voters of the county, it shall not be sold or disposed of except after referendum approval thereof by a majority of the voters of the county voting thereon.
If the home was erected after referendum approval by the voters of the county, the county nursing home may be leased upon the vote of a 3/5 majority of all the members of the board.
10. To operate a sheltered care home as a part of a county nursing home provided that a license to do so is obtained pursuant to the Nursing Home Care Act, as amended.
(Source: P.A. 99-581, eff. 1-1-17.)

****************************************************************************************

Unanswered Questions:

1.Currently—are the taxpayers paying any type of property taxes for the operation of Maple Crest Care Centre?

2. What are the general terms under the current lease as far as annual rent and maintenance costs?  What is the current net loss or gain to the county budget?

3. The facility is being operated by a for profit corporation. Are property taxes being paid on the property? What is the accessed valuation of the property both for tax purposes and insurance coverage?  If there is a recent market appraisal, what is that value?

4. Does the county currently have any say in the patient rates or the number of public aid patients?